Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
VECTOR, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 85%, Sep-Nov Ordinary Profit Increases by 74%
6058 VECTOR INC. 【J-GAAP】
Earnings ReportVECTOR INC. <6058> [TSE Prime] announced its financial results after the market closed on January 14th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending February 2026 (March to November) expanded 7.33 billion yen, an increase 85.1% compared to the same period last year. Progress toward the full-year plan of 8.30 billion yen was 88.4%, also surpassing the five-year average of 68.4%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the December to February period (4Q) is expected to significant drop 73.9% from the same period last year to 0.96 billion yen.
In the most recent three-month period, from September to November (3Q), the consolidated ordinary profit increased 74.5% from the same period last year, reaching 3.42 billion yen. The operating profit margin jumped from 12.9% in the same period last year to 20.5%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar - Nov, 2023 | 43,428 | 3,497 | 3,610 | 2,987 | 62.5 | 52.5 | Jan 12, 2024 | J-GAAP |
| Mar - Nov, 2024 | 42,452 | 4,008 | 3,964 | 2,034 | 43.4 | 51.8 | Jan 14, 2025 | J-GAAP |
| Mar - Nov, 2025 | 46,689 | 7,198 | 7,337 | 3,619 | 77.2 | 88.4 | Jan 14, 2026 | J-GAAP |
| YoY | +10.0% | +79.6% | +85.1% | +77.9% | +78.0% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep - Feb, 2024 | 31,869 | 5,960 | 5,655 | 3,176 | 67.7 | 32 | Apr 14, 2025 | J-GAAP |
| Sep - Feb, 2025 Guidance | 33,251 | 4,770 | 4,390 | 3,235 | 69.0 | 33 | Oct 15, 2025 | J-GAAP |
| YoY | +4.3% | -20.0% | -22.4% | +1.9% | +1.9% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Feb, 2024 | 59,212 | 6,939 | 6,871 | 4,684 | 98.1 | 29 | Apr 12, 2024 | J-GAAP |
| Feb, 2025 | 59,254 | 8,029 | 7,655 | 4,195 | 89.4 | 32 | Apr 14, 2025 | J-GAAP |
| Feb, 2026 Guidance | 63,000 | 8,500 | 8,300 | 5,000 | 106.6 | 33 | Apr 14, 2025 | J-GAAP |
| YoY | +6.3% | +5.9% | +8.4% | +19.2% | +19.2% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep - Nov, 2024 | 15,067 | 1,939 | 1,964 | 1,015 | 21.6 | 12.9 | Jan 14, 2025 | J-GAAP |
| Dec - Feb, 2024 | 16,802 | 4,021 | 3,691 | 2,161 | 46.1 | 23.9 | Apr 14, 2025 | J-GAAP |
| Mar - May, 2025 | 14,802 | 1,689 | 1,698 | 767 | 16.4 | 11.4 | Jul 15, 2025 | J-GAAP |
| Jun - Aug, 2025 | 14,947 | 2,041 | 2,212 | 998 | 21.3 | 13.7 | Oct 15, 2025 | J-GAAP |
| Sep - Nov, 2025 | 16,940 | 3,468 | 3,427 | 1,854 | 39.5 | 20.5 | Jan 14, 2026 | J-GAAP |
| YoY | +12.4% | +78.9% | +74.5% | +82.7% | +82.7% |
Related Articles
Medical Net , First Half Ordinary Profit Unexpectedly Revised Upward by 2.5 times
Ichigo, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 39%
TKP, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 8%, Raises Record High Profit Forecast
EAT&HOLDINGS, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 17%, Sep-Nov Ordinary Profit Increases by 5.1 times
Chordia Therapeutics, Sep-Nov (1Q) Ordinary Profit Loss Narrows
SHIKIGAKU, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 45%
KOWA, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 25%, Sep-Nov Ordinary Profit Decreases by 17%
Pacific Net, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 11%, Raises Record High Profit Forecast
HIMARAYA, Sep-Nov (1Q) Ordinary Profit Loss Widens
CHIIKISHINBUNSHA, Sep-Nov (1Q) Ordinary Profit Turns to Loss